Waldenström Macroglobulinemia: A Plasma Cell Neoplasm with IgM Monoclonal Gammopathy

Waldenström macroglobulinemia (WM) is a rare, indolent B-cell lymphoproliferative disorder classified as a plasma cell neoplasm (specifically, a lymphoplasmacytic lymphoma with an IgM monoclonal gammopathy).

Key Features

  • Clonal expansion of lymphoplasmacytic cells in bone marrow, lymph nodes, and spleen.
  • Overproduction of monoclonal immunoglobulin M (IgM), causing hyperviscosity syndrome in advanced cases.
  • Median age at diagnosis: ~70 years.
  • Genetic hallmark: MYD88 L265P mutation (>90% of cases); CXCR4 mutations in ~30–40%.

Clinical Presentation

  • Fatigue, weight loss, night sweats (B symptoms).
  • Hyperviscosity: visual changes, headaches, bleeding, neurologic symptoms.
  • Anemia, thrombocytopenia (marrow infiltration).
  • Peripheral neuropathy (anti-myelin-associated glycoprotein antibodies).
  • Hepatosplenomegaly, lymphadenopathy.

Management

Asymptomatic patients may be observed. Treatment (e.g., BTK inhibitors like ibrutinib, rituximab-based regimens, plasmapheresis for acute hyperviscosity) is initiated for symptomatic disease. Prognosis is generally favorable with modern therapies.

Blood Disorders - Related Articles